KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Mahwah, New Jersey and currently employs 73 full-time employees. The firm is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The firm is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
根據最新的財務報表(Form-10K),KORU Medical Systems Inc 的總資產為 $0,淨isProfitable}為 $0
KRMD 的關鍵財務比率是什麼?
KORU Medical Systems Inc 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
KORU Medical Systems Inc 的收入按細分市場或地理位置如何劃分?
KORU Medical Systems Inc の最大収益セグメントは Domestic Core で、最新の利益発表における収益は 27,992,436 です。地域別に見ると、United States が KORU Medical Systems Inc の主要市場であり、収益は 30,238,333 です。